Short Interest in PureTech Health plc (OTCMKTS:PTCHF) Expands By 69.4%

PureTech Health plc (OTCMKTS:PTCHF) was the recipient of a significant increase in short interest during the month of January. As of January 30th, there was short interest totaling 56,594 shares, an increase of 69.4% from the January 15th total of 33,408 shares. Based on an average daily trading volume, of 144,900 shares, the days-to-cover ratio is presently 0.4 days. Based on an average daily trading volume, of 144,900 shares, the days-to-cover ratio is presently 0.4 days.

PureTech Health Price Performance

PureTech Health stock opened at $1.70 on Friday. PureTech Health has a twelve month low of $1.27 and a twelve month high of $1.90. The company’s 50-day moving average price is $1.72 and its two-hundred day moving average price is $1.70.

PureTech Health Company Profile

PureTech Health PLC (“PureTech”) is a clinical-stage biopharmaceutical company focused on the development of innovative medicines to address serious diseases with high unmet medical need. Founded in 2005 by Daphne Zohar and headquartered in Boston, Massachusetts with operations in both North America and Europe, PureTech applies its proprietary platforms to advance therapeutic candidates across immunology, neuroscience and lymphatic-focused indications.

The company leverages three core technology platforms—immune tolerance, gut-targeted delivery and lymphatic transport—to develop novel molecules designed for enhanced specificity and durability of effect.